A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis-Reference-Cited by-同舟云学术

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Published:2018-06-07 Issue:23 Volume:378 Page:2171-2181
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Corpechot Christophe¹,Chazouillères Olivier¹,Rousseau Alexandra¹,Le Gruyer Antonia¹,Habersetzer François¹,Mathurin Philippe¹,Goria Odile¹,Potier Pascal¹,Minello Anne¹,Silvain Christine¹,Abergel Armand¹,Debette-Gratien Maryline¹,Larrey Dominique¹,Roux Olivier¹,Bronowicki Jean-Pierre¹,Boursier Jérôme¹,de Ledinghen Victor¹,Heurgue-Berlot Alexandra¹,Nguyen-Khac Eric¹,Zoulim Fabien¹,Ollivier-Hourmand Isabelle¹,Zarski Jean-Pierre¹,Nkontchou Gisèle¹,Lemoinne Sara¹,Humbert Lydie¹,Rainteau Dominique¹,Lefèvre Guillaume¹,de Chaisemartin Luc¹,Chollet-Martin Sylvie¹,Gaouar Farid¹,Admane Farid-Hakeem¹,Simon Tabassome¹,Poupon Raoul¹

Affiliation:

1. From the Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, Hepatology and Gastroenterology Department, Saint-Antoine University Hospital, Assistance Publique–Hôpitaux de Paris (APHP) (C.C., O.C., S.L., F.G., R.P.), INSERM Unité Mixte de Recherche (UMR) S938 (C.C., O.C., S.L., R.P.) and the Biochemistry Laboratory (L.H., D.R.), Saint-Antoine University Hospital, APHP, INSERM Unité 1157/UMR 7203, Sorbonne University, the Biochemistry Laboratory, Tenon University Hospital, APHP (G...

Funder

Arrow Génériques, Lyon, France

Assistance Publique – Hôpitaux de Paris, Paris, France

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1714519

Cited by 418 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Dual PPAR δ/γ Partial Agonist Induces Hepatic Lipid Accumulation through Direct Binding and Inhibition of AKT1 Phosphorylation, Mediating CD36 Upregulation;Chemical Research in Toxicology;2024-09-05

2. Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort;Zeitschrift für Gastroenterologie;2024-09-03

3. Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis;Digestive and Liver Disease;2024-09

4. Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis;GASTROENTEROLOGY;2024

5. Primary biliary cholangitis;The Lancet;2024-09